GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jin Medical International Ltd (NAS:ZJYL) » Definitions » ROE %

Jin Medical International (Jin Medical International) ROE % : 9.36% (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Jin Medical International ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Jin Medical International's annualized net income for the quarter that ended in Sep. 2023 was $2.22 Mil. Jin Medical International's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $23.76 Mil. Therefore, Jin Medical International's annualized ROE % for the quarter that ended in Sep. 2023 was 9.36%.

The historical rank and industry rank for Jin Medical International's ROE % or its related term are showing as below:

ZJYL' s ROE % Range Over the Past 10 Years
Min: 13.76   Med: 19.46   Max: 21.2
Current: 13.76

During the past 4 years, Jin Medical International's highest ROE % was 21.20%. The lowest was 13.76%. And the median was 19.46%.

ZJYL's ROE % is ranked better than
84.62% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 0.15 vs ZJYL: 13.76

Jin Medical International ROE % Historical Data

The historical data trend for Jin Medical International's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jin Medical International ROE % Chart

Jin Medical International Annual Data
Trend Sep20 Sep21 Sep22 Sep23
ROE %
20.42 21.20 18.50 14.68

Jin Medical International Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Get a 7-Day Free Trial 11.28 16.59 19.26 18.21 9.36

Competitive Comparison of Jin Medical International's ROE %

For the Medical Instruments & Supplies subindustry, Jin Medical International's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jin Medical International's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jin Medical International's ROE % distribution charts can be found below:

* The bar in red indicates where Jin Medical International's ROE % falls into.



Jin Medical International ROE % Calculation

Jin Medical International's annualized ROE % for the fiscal year that ended in Sep. 2023 is calculated as

ROE %=Net Income (A: Sep. 2023 )/( (Total Stockholders Equity (A: Sep. 2022 )+Total Stockholders Equity (A: Sep. 2023 ))/ count )
=2.878/( (15.236+23.979)/ 2 )
=2.878/19.6075
=14.68 %

Jin Medical International's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=2.224/( (23.547+23.979)/ 2 )
=2.224/23.763
=9.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


Jin Medical International  (NAS:ZJYL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=2.224/23.763
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2.224 / 19.136)*(19.136 / 31.9625)*(31.9625 / 23.763)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.62 %*0.5987*1.3451
=ROA %*Equity Multiplier
=6.96 %*1.3451
=9.36 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=2.224/23.763
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (2.224 / 2.504) * (2.504 / 2.192) * (2.192 / 19.136) * (19.136 / 31.9625) * (31.9625 / 23.763)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8882 * 1.1423 * 11.45 % * 0.5987 * 1.3451
=9.36 %

Note: The net income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Jin Medical International ROE % Related Terms

Thank you for viewing the detailed overview of Jin Medical International's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jin Medical International (Jin Medical International) Business Description

Traded in Other Exchanges
N/A
Address
No. 33 Lingxiang Road,, Wujin District, Jiangsu Province, Changzhou City, CHN, KY1-1205
Website
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.

Jin Medical International (Jin Medical International) Headlines

From GuruFocus